1. Home
  2. REGN vs CTAS Comparison

REGN vs CTAS Comparison

Compare REGN & CTAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regeneron Pharmaceuticals Inc.

REGN

Regeneron Pharmaceuticals Inc.

HOLD

Current Price

$790.24

Market Cap

68.8B

Sector

Health Care

ML Signal

HOLD

Logo Cintas Corporation

CTAS

Cintas Corporation

HOLD

Current Price

$200.29

Market Cap

80.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
REGN
CTAS
Founded
1988
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
68.8B
80.3B
IPO Year
1995
1994

Fundamental Metrics

Financial Performance
Metric
REGN
CTAS
Price
$790.24
$200.29
Analyst Decision
Buy
Hold
Analyst Count
25
10
Target Price
★ $830.16
$215.80
AVG Volume (30 Days)
526.4K
★ 1.8M
Earning Date
04-29-2026
03-25-2026
Dividend Yield
0.55%
★ 1.03%
EPS Growth
8.19
★ 11.59
EPS
★ 18.95
4.91
Revenue
$5,872,227,000.00
★ $6,892,303,000.00
Revenue This Year
$12.45
$10.75
Revenue Next Year
$10.13
$7.52
P/E Ratio
$42.01
★ $40.26
Revenue Growth
★ 20.82
N/A
52 Week Low
$541.00
$161.16
52 Week High
$859.34
$219.17

Technical Indicators

Market Signals
Indicator
REGN
CTAS
Relative Strength Index (RSI) 48.83 51.61
Support Level $758.85 $197.73
Resistance Level $818.06 $206.72
Average True Range (ATR) 17.66 3.92
MACD -3.06 -0.27
Stochastic Oscillator 40.15 67.85

Price Performance

Historical Comparison
REGN
CTAS

About REGN Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.

About CTAS Cintas Corporation

Cintas has roots dating back to 1929, when the Farmer family cleaned and resold dirty rags to manufacturing plants in Ohio. The firm has expanded its business organically and through acquisitions, and today Cintas acts as a one-stop outsourcing partner for businesses. Cintas will design, manufacture, collect, and clean every employee uniform for a small weekly sum, taking on the upfront capital expense itself. At the same stop, Cintas can also replace soiled or depleted mats, mops, trash liners, towels, first aid supplies, fire extinguishers, and cleaning products. Businesses value an outsourcing partner like Cintas as it simplifies operations and leaves noncore tasks with high regulatory standards in the hands of professionals.

Share on Social Networks: